Why the study?
Does serum cathepsin B-like activity differentiate ovarian carcinomas from benign ovarian or uterine tumours?
Population
75 patients with ovarian carcinomas and control groups consisting of 15 healthy women, 20 patients with…
Comparison
Measurement of serum cathepsin B-like activity vs Control groups
Design
Case-control
Authors
Loading...
May support preoperative differentiation of ovarian cancer; leaves open validation as a biomarker in prospective studies.
Does serum cathepsin B-like activity differentiate ovarian carcinomas from benign ovarian or uterine tumours?
Serum cathepsin B-like activity may serve as a useful preoperative biomarker to differentiate ovarian carcinomas from benign ovarian or uterine tumours.
Warwas et al. (1997) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: